|
-Original-
Sentinel Lymph Node Detection, Location, and Number on SPECT/CT Can Help Predict Pathological Axillary Lymph Node Metastasis in Women with Breast Cancer
1Department of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo, Japan
2Department of Radiology, Nippon Medical School Hospital, Tokyo, Japan
3Department of Breast Surgery and Oncology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan
4Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan
Background: Use of radiocolloids for sentinel lymph node (SLN) detection in breast cancer (BC) offers the advantage of utilizing single-photon emission computed tomography/computed tomography (SPECT/CT). This study explored whether SPECT/CT findings can predict pathological axillary lymph node (ALN) metastasis.
Methods: A consecutive series of patients with invasive BC (clinical stage, T1-3, N0, and M0) who underwent SLN biopsy (SLNB) using SPECT/CT between January 2011 and December 2016 were included. SLN detection, location, and number on SPECT/CT, number of excised SLNs, and clinical and pathological characteristics were analyzed in relation to pathological ALN metastasis.
Results: Data from 408 patients (412 cases) with BC were analyzed. Patient age ranged from 28 to 93 years (mean: 59). SPECT/CT identified one to four SLNs (mean: 1.3) in 407 cases (98.8%) and no SLNs in 5 cases (1.2%). Of the 407 cases with at least one identified SLN, SLNs were solely in level I of the axilla in 394 cases (96.8%), both in and outside level I in 12 (2.9%), and solely outside of level I in 1 (0.2%). The number of ALNs removed via SLNB ranged from one to eight (mean: 2.0). SPECT/CT findings, including absence of SLN detection (P<0.001), SLN locations outside of axillary level I (P<0.001), and an increased number of SLNs (P=0.034), as well as removal of ≥3 SLNs (P=0.028), were significantly correlated with pathological ALN metastasis.
Conclusions: SLNB with SPECT/CT yields useful information on pathological ALN metastasis in BC patients.
J Nippon Med Sch 2025; 92: 170-180
Keywords
breast cancer, sentinel lymph node biopsy, SPECT/CT, axillary lymph node metastasis
Correspondence to
Hiroyuki Takei, MD, PhD, Department of Breast Surgery and Oncology, Nippon Medical School Hospital, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
takei-hiroyuki@nms.ac.jp
Received, November 16, 2024
Accepted, December 25, 2024